276 related articles for article (PubMed ID: 27080182)
21. Synthesis and biological evaluation of novel coumarin-pyrazoline hybrids endowed with phenylsulfonyl moiety as antitumor agents.
Amin KM; Eissa AA; Abou-Seri SM; Awadallah FM; Hassan GS
Eur J Med Chem; 2013 Feb; 60():187-98. PubMed ID: 23291120
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of novel 1,2,3-triazole linked coumarinopyrazole conjugates as potent anticholinesterase, anti-5-lipoxygenase, anti-tyrosinase and anti-cancer agents.
Chekir S; Debbabi M; Regazzetti A; Dargère D; Laprévote O; Ben Jannet H; Gharbi R
Bioorg Chem; 2018 Oct; 80():189-194. PubMed ID: 29940340
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and in vitro evaluation of 3-(4-nitrophenyl)coumarin derivatives in tumor cell lines.
Musa MA; Latinwo LM; Virgile C; Badisa VL; Gbadebo AJ
Bioorg Chem; 2015 Feb; 58():96-103. PubMed ID: 25553414
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and Biological Evaluation of Novel Thiazolyl-Coumarin Derivatives as Potent Histone Deacetylase Inhibitors with Antifibrotic Activity.
Pardo-Jiménez V; Navarrete-Encina P; Díaz-Araya G
Molecules; 2019 Feb; 24(4):. PubMed ID: 30791388
[TBL] [Abstract][Full Text] [Related]
25. An efficient one-pot approach for the regio- and diastereoselective synthesis of trans-dihydrofuran derivatives: cytotoxicity and DNA-binding studies.
Tangella Y; Manasa KL; Laxma Nayak V; Sathish M; Sridhar B; Alarifi A; Nagesh N; Kamal A
Org Biomol Chem; 2017 Aug; 15(32):6837-6853. PubMed ID: 28782777
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, molecular docking studies of coumarinyl-pyrazolinyl substituted thiazoles as non-competitive inhibitors of mushroom tyrosinase.
Saeed A; Mahesar PA; Channar PA; Abbas Q; Larik FA; Hassan M; Raza H; Seo SY
Bioorg Chem; 2017 Oct; 74():187-196. PubMed ID: 28837887
[TBL] [Abstract][Full Text] [Related]
27. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
Ma CC; Liu ZP
Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R
Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.
Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD
Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of 4H-chromene, coumarin, 12H-chromeno[2,3-d]pyrimidine derivatives and some of their antimicrobial and cytotoxicity activities.
Sabry NM; Mohamed HM; Khattab ES; Motlaq SS; El-Agrody AM
Eur J Med Chem; 2011 Feb; 46(2):765-72. PubMed ID: 21216502
[TBL] [Abstract][Full Text] [Related]
31. Design, Synthesis, and Biological Evaluation of Coumarin-Triazole Hybrid Molecules as Potential Antitumor and Pancreatic Lipase Agents.
Kahveci B; Yılmaz F; Menteşe E; Ülker S
Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28543820
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and tyrosinase inhibitory properties of novel isoquinoline urea/thiourea derivatives.
Genç H; Zengin M; Yavuz E; Gençer N; Arslan O
Artif Cells Nanomed Biotechnol; 2014 Jun; 42(3):178-85. PubMed ID: 23590347
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents.
Luo G; Muyaba M; Lyu W; Tang Z; Zhao R; Xu Q; You Q; Xiang H
Bioorg Med Chem Lett; 2017 Feb; 27(4):867-874. PubMed ID: 28110871
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic anticancer activity of a novel geranylgeranylated coumarin derivative.
Devji T; Reddy C; Woo C; Awale S; Kadota S; Carrico-Moniz D
Bioorg Med Chem Lett; 2011 Oct; 21(19):5770-3. PubMed ID: 21880488
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of some new carbonitriles and pyrazole coumarin derivatives with potent antitumor and antimicrobial activities.
Hafez OM; Nassar MI; El-Kousy SM; Abdel-Razik AF; Sherien MM; El-Ghonemy MM
Acta Pol Pharm; 2014; 71(4):594-601. PubMed ID: 25272885
[TBL] [Abstract][Full Text] [Related]
36. Click chemistry inspired synthesis and bioevaluation of novel triazolyl derivatives of osthol as potent cytotoxic agents.
Farooq S; Shakeel-u-Rehman ; Hussain A; Hamid A; Qurishi MA; Koul S
Eur J Med Chem; 2014 Sep; 84():545-54. PubMed ID: 25062005
[TBL] [Abstract][Full Text] [Related]
37. Novel inhibitors of human histone deacetylases: design, synthesis and bioactivity of 3-alkenoylcoumarines.
Seidel C; Schnekenburger M; Zwergel C; Gaascht F; Mai A; Dicato M; Kirsch G; Valente S; Diederich M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3797-801. PubMed ID: 25042254
[TBL] [Abstract][Full Text] [Related]
38. Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity.
Wu XQ; Huang C; Jia YM; Song BA; Li J; Liu XH
Eur J Med Chem; 2014 Mar; 74():717-25. PubMed ID: 24119869
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationship studies of 4-methylcoumarin derivatives as anticancer agents.
Miri R; Nejati M; Saso L; Khakdan F; Parshad B; Mathur D; Parmar VS; Bracke ME; Prasad AK; Sharma SK; Firuzi O
Pharm Biol; 2016; 54(1):105-10. PubMed ID: 26017566
[TBL] [Abstract][Full Text] [Related]
40. Current developments of coumarin-based anti-cancer agents in medicinal chemistry.
Emami S; Dadashpour S
Eur J Med Chem; 2015 Sep; 102():611-30. PubMed ID: 26318068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
